Giapreza 2.5 mg/ml concentrate for solution for infusion

Radioembolization with Intra-arterial Angiotensin II to improve Tumor-absorbed dose: The RADIANT study

A Prospective Angiotensin II versus Noradrenaline trial for Hypotension management to reduce cardiac-surgery associated Acute Kidney Injury (PAN-AKI)

A phase III randomised, double-blind, placebo-controlled, multicentre efficacy and safety clinical trial of angiotensin II in paediatric patients of 0 to 17 years of age with refractory hypotension in distributive shock receiving fluid resuscitation and standard-of-care vasopressors